Want to see TSE:TELO full AI Analyst Report?
Telo Genomics Corp (TELO) Income Statement
Telo Genomics Corp Income Statement
Last quarter (Q4 2026), Telo Genomics Corp's total revenue was $0.00. In Q4, Telo Genomics Corp's net income was $-681.95K. See Telo Genomics Corp’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Sep 25 | Sep 24 | Jun 22 | Sep 20 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -86.56K | $ -14.45K | $ -39.54K | $ -33.11K | $ -62.23K | |
| $ 2.10M | $ 2.70M | $ 2.68M | $ 2.82M | $ 1.26M | |
| Depreciation and Amortization | $ 86.56K | $ 14.45K | $ 39.54K | $ 33.11K | $ 62.23K |
| $ -2.10M | $ -2.69M | $ -2.67M | $ -2.78M | $ -1.01M | |
| $ -2.19M | $ -2.70M | $ -2.72M | $ -2.82M | $ -1.25M | |
| $ -138.44K | $ -16.37K | $ 5.39K | $ -5.21K | $ 182.61K | |
| $ -2.33M | $ -2.72M | $ -2.71M | $ -2.82M | $ -1.07M | |
| $ -2.31M | $ -2.72M | $ -2.71M | $ -2.82M | $ -1.07M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.03 | $ -0.04 | $ -0.05 | $ -0.02 |
| Diluted EPS | $ -0.02 | $ -0.03 | $ -0.04 | $ -0.05 | $ -0.02 |
| Weighted Average Shares Outstanding | 100.32M | 87.74M | 71.38M | 60.15M | 46.89M |
| Weighted Average Shares Outstanding (Diluted) | 100.32M | 87.74M | 71.38M | 60.15M | 46.89M |
Currency in CAD
